Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis Post author:Sam Post published:October 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>VANC Pharmaceuticals</b> Announces Non Brokered Private Placement July 20, 2017 Scandal-Ridden INSYS Replaced 90% of Its Original Sales Force in Makeover October 8, 2017 GlaxoSmithKline CEO Continues Restructuring With Job Cuts in Africa January 17, 2018